Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SMOX | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
mRNA | ABTB2 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
mRNA | COX19 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-05 |
mRNA | FAM83H | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-05 |
mRNA | EGR3 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |
mRNA | DDB2 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
mRNA | C19orf33 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-05 |
mRNA | TINAGL1 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-05 |
mRNA | WWC1 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-05 |
mRNA | LAMA4 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-05 |